Compare Aurobindo Pharma with HIKAL CHEMIC - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs HIKAL. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA HIKAL. AUROBINDO PHARMA/
HIKAL.
 
P/E (TTM) x 11.4 20.3 56.2% View Chart
P/BV x 1.4 3.5 39.9% View Chart
Dividend Yield % 0.8 0.8 101.3%  

Financials

 AUROBINDO PHARMA   HIKAL.
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-21
HIKAL.
Mar-21
AUROBINDO PHARMA/
HIKAL.
5-Yr Chart
Click to enlarge
High Rs1,023204 500.5%   
Low Rs33367 496.8%   
Sales per share (Unadj.) Rs422.8139.5 303.0%  
Earnings per share (Unadj.) Rs92.010.8 851.8%  
Cash flow per share (Unadj.) Rs110.017.7 621.0%  
Dividends per share (Unadj.) Rs4.002.00 200.0%  
Avg Dividend yield %0.61.5 40.0%  
Book value per share (Unadj.) Rs374.375.7 494.4%  
Shares outstanding (eoy) m585.94123.30 475.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.61.0 164.9%   
Avg P/E ratio x7.412.6 58.7%  
P/CF ratio (eoy) x6.27.7 80.5%  
Price / Book Value ratio x1.81.8 101.1%  
Dividend payout %4.318.5 23.5%   
Avg Mkt Cap Rs m397,39816,738 2,374.2%   
No. of employees `000NANA-   
Total wages/salary Rs m35,3501,643 2,151.3%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m247,74617,204 1,440.0%  
Other income Rs m3,80950 7,644.5%   
Total revenues Rs m251,55517,254 1,457.9%   
Gross profit Rs m81,4803,229 2,523.5%  
Depreciation Rs m10,554852 1,238.1%   
Interest Rs m745362 205.8%   
Profit before tax Rs m73,9902,064 3,584.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m20,098733 2,742.4%   
Profit after tax Rs m53,8921,331 4,047.8%  
Gross profit margin %32.918.8 175.2%  
Effective tax rate %27.235.5 76.5%   
Net profit margin %21.87.7 281.1%  
BALANCE SHEET DATA
Current assets Rs m198,2359,251 2,142.8%   
Current liabilities Rs m106,6527,033 1,516.4%   
Net working cap to sales %37.012.9 286.7%  
Current ratio x1.91.3 141.3%  
Inventory Days Days1926 73.1%  
Debtors Days Days52103 50.1%  
Net fixed assets Rs m135,77810,906 1,245.0%   
Share capital Rs m586247 237.6%   
"Free" reserves Rs m218,7139,087 2,406.8%   
Net worth Rs m219,2999,334 2,349.5%   
Long term debt Rs m1,6842,629 64.1%   
Total assets Rs m334,01320,157 1,657.1%  
Interest coverage x100.36.7 1,496.8%   
Debt to equity ratio x00.3 2.7%  
Sales to assets ratio x0.70.9 86.9%   
Return on assets %16.48.4 194.7%  
Return on equity %24.614.3 172.3%  
Return on capital %33.820.3 166.8%  
Exports to sales %53.868.7 78.3%   
Imports to sales %16.426.9 61.0%   
Exports (fob) Rs m133,24811,823 1,127.1%   
Imports (cif) Rs m40,6154,623 878.5%   
Fx inflow Rs m133,24811,823 1,127.1%   
Fx outflow Rs m44,9464,623 972.2%   
Net fx Rs m88,3027,200 1,226.5%   
CASH FLOW
From Operations Rs m33,2892,290 1,453.6%  
From Investments Rs m5,987-1,562 -383.3%  
From Financial Activity Rs m-13,648-969 1,408.9%  
Net Cashflow Rs m25,831-240 -10,742.3%  

Share Holding

Indian Promoters % 48.8 68.8 70.9%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 38.3 7.8 490.4%  
FIIs % 20.8 6.9 301.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 31.2 154.2%  
Shareholders   338,639 75,341 449.5%  
Pledged promoter(s) holding % 14.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    

Yellow Ad

Advertisement

Our FREE Guide: Small Caps That Will Race Ahead of the Sensex

Richa Agarwal, our head of smallcap research, recently released the updated version of her very popular guide:

'Small Caps That Will Race Ahead of the Sensex':

When you sign-up for Richa's One Stock Crorepati mega summit, you get this premium guide worth Rs 950 for absolutely FREE.:

Learn more



Today's Market

Sensex Continues Momentum, ends 433 Points Higher; IT & Metal Stocks Witness Buying(Closing)

Indian share markets witnessed positive trading activity throughout the day today and ended higher.

Related Views on News

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Why Tata Power Share Price is Falling(Views On News)

Jun 14, 2022

Here's why shares of Tata Power have fallen in recent days.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

When Will the Stock Market Recover?(Views On News)

Jun 15, 2022

This is how you can tell the market is going to recover.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Jun 27, 2022 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA - ZENOTECH LABS COMPARISON

COMPARE AUROBINDO PHARMA WITH

MARKET STATS